Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) soared at $1.79, representing a gain of 38.8%. On Tue, Feb 28, 2023, BLPH:NASDAQ touched a New 2-Week High of $1.79. The stock appeared on our News Catalysts scanner on Thu, Feb 09, 2023 at 09:43 AM in the 'BIOTECH' category. From Tue, Feb 14, 2023, the stock recorded 44.44% Up Days and 60.00% Green Days
The stock spiked on Thu, Jan 05, 2023 at $3.5 with a volume of 59M+.
About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.
Top 10 Gainers:
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 169.53%
- Fidelity Southern Corporation (LION:NASDAQ), 97.83%
- Lucira Health Inc. (LHDX:NASDAQ), 82.35%
- Bioventus Inc. (BVS:NASDAQ), 45.89%
- ObsEva SA (OBSV:NASDAQ), 43.15%
- Peak Bio Inc Com (PKBO:NASDAQ), 40.85%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- Mmtec, Inc. (MTC:NASDAQ), 40.24%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 38.76%
- Sky Harbour Group Corporation Class A (SKYH:NYSEMKT), 36.43%